{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:18:28Z","timestamp":1792145908947,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.neuropharm.2012.04.013","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T11:53:06Z","timestamp":1335786786000},"page":"184-194","source":"Crossref","is-referenced-by-count":250,"special_numbering":"C","title":["Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice"],"prefix":"10.1016","volume":"68","author":[{"given":"Francesco","family":"Matrisciano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Tueting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishani","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashkim","family":"Kadriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.04.013_bib1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/cercor\/5.6.550","article-title":"GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls","volume":"5","author":"Akbarian","year":"1995","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainresbull.2010.04.008","article-title":"Mouse behavioral endophenotypes for schizophrenia","volume":"83","author":"Amann","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib3","series-title":"The Handbook of Neurochemistry and Molecular Neurobiology","first-page":"341","article-title":"Nucleic acid quantitation using the competitive polymerase chain reaction: practical neurochemistry methods","author":"Auta","year":"2007"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1023\/A:1025388901248","article-title":"The developmental origins of adult disease","volume":"18","author":"Barker","year":"2003","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib5","doi-asserted-by":"crossref","first-page":"10164","DOI":"10.1073\/pnas.0703806104","article-title":"Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars","volume":"104","author":"Benes","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib6","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.neuropharm.2010.12.011","article-title":"Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders","volume":"60","author":"Benes","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0893-133X(01)00360-8","article-title":"Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia","volume":"26","author":"Borrell","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(00)00139-0","article-title":"Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia","volume":"49","author":"Braff","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","article-title":"Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia","volume":"23","author":"Breese","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0149-7634(02)00011-8","article-title":"Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness","volume":"26","author":"Breese","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00005053-199602000-00003","article-title":"Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia","volume":"184","author":"Brown","year":"1996","journal-title":"J.\u00a0Nerv. Ment. Dis."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1176\/appi.ajp.2011.11050722","article-title":"Further evidence of infectious insults in the pathogenesis and pathophysiology of schizophrenia","volume":"168","author":"Brown","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib13","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.neuropharm.2004.02.001","article-title":"Enhanced dizocilpine efficacy in heterozygous reeler mice relates to GABA turnover downregulation","volume":"46","author":"Carboni","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.mp.4000783","article-title":"Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression","volume":"5","author":"Fatemi","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2007.11.018","article-title":"Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders","volume":"99","author":"Fatemi","year":"2008","journal-title":"Scizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbr.2007.04.016","article-title":"Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy","volume":"181","author":"Fortier","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/npp.2011.221","article-title":"Growth arrest and DNA-damage-inducible, Beta (GADD45b)-mediated DNA demethylation in major psychosis","volume":"37","author":"Gavin","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib18","doi-asserted-by":"crossref","first-page":"e15367","DOI":"10.1371\/journal.pone.0015367","article-title":"Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates","volume":"5","author":"Globisch","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-0004.1994.tb04213.x","article-title":"Complications to the complex inheritance f schizophrenia","volume":"46","author":"Gottesman","year":"1994","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib20","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1073\/pnas.0503736102","article-title":"Reelin promoter hypermethylation in schizophrenia","volume":"102","author":"Grayson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pharmthera.2005.01.007","article-title":"The human reelin gene: transcription factors (+), repressors (\u2212) and the methylation switch (+\/\u2212) in schizophrenia","volume":"111","author":"Grayson","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib22","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.2217\/epi.10.22","article-title":"Schizophrenia and the epigenetic hypothesis","volume":"2","author":"Grayson","year":"2010","journal-title":"Epigenomics"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib23","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"7","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","article-title":"GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon","volume":"180","author":"Guidotti","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","article-title":"Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling","volume":"30","author":"Guidotti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuropharm.2010.10.021","article-title":"Epigenetic GABAergic targets in schizophrenia and bipolar disorder","volume":"60","author":"Guidotti","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib27","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.4161\/cc.10.16.17093","article-title":"Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond","volume":"10","author":"Guo","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib28","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1017\/S1461145704004122","article-title":"Pathways to schizophrenia: the impact of environmental factors","volume":"7","author":"Howes","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib29","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1371\/journal.pone.0000809","article-title":"GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia","volume":"2","author":"Huang","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0006-3223(98)00359-X","article-title":"Scizophrenia and the influenza epidemics of 1957 in Japan","volume":"46","author":"Izumoto","year":"1999","journal-title":"Biol. Psych."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0074-7742(06)78003-5","article-title":"Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions","volume":"78","author":"Javitt","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib32","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1093\/nar\/gkr120","article-title":"Genomic mapping of 5-hydroxymethylcytosine in the human brain","volume":"39","author":"Jin","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib33","article-title":"The DNA methyltransferases1 (DNMT1) and 3a (DNMT3a) co-localize with GAD67-positive neurons in the GAD67-GFP mouse brain","author":"Kadriu","year":"2011","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1471-4159.2003.01873.x","article-title":"Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal pole","volume":"86","author":"Kinnunen","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0893-133X(01)00396-7","article-title":"Glucocorticoid hormones and early brain development in schizophrenia","volume":"27","author":"Koenig","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbr.2004.05.030","article-title":"Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia","volume":"156","author":"Koenig","year":"2005","journal-title":"Behave. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.108.051763","article-title":"The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes","volume":"75","author":"Kundakovic","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib38","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1073\/pnas.97.20.11032","article-title":"Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus","volume":"97","author":"Lemaire","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","article-title":"Scizophrenia as a disorder of neurodevelopment","volume":"25","author":"Lewis","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00213-010-2035-0","article-title":"Prenatal stress: role in psychotic and depressive diseases","volume":"214","author":"Markham","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib43","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0028-3908(02)00057-6","article-title":"Imipramine treatment up-regulates the expression and function of mGlu2\/3 metabotropic glutamate receptors in the rat hippocampus","volume":"42","author":"Matrisciano","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib44","article-title":"Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice","author":"Matrisciano","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib45","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nn1110-1313","article-title":"Epigenetic regulation of the neural transcriptome: the meaning of the marks","volume":"13","author":"Meaney","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/schbul\/20.2.263","article-title":"Prenatal influenza infections and adult schizophrenia","volume":"20","author":"Mednick","year":"1994","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0031-9384(00)00431-5","article-title":"Effects of stress during pregnancy on maternal behavior in mice","volume":"72","author":"Meek","year":"2001","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00213-010-2137-8","article-title":"The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment","volume":"213","author":"Meltzer","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib49","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2008.01.008","article-title":"Epigenomic profiling reveals DNA-methylation changes associated with major psychosis","volume":"82","author":"Mill","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib50","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/schbul\/sbn080","article-title":"Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications","volume":"34","author":"Mittal","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib51","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1523\/JNEUROSCI.4230-10.2011","article-title":"Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT2A and mGlu2 receptors in the adult offspring","volume":"31","author":"Moreno","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib52","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/nn.2436","article-title":"Dynamic DNA methylation programs persistent adverse effects of early-life stress","volume":"12","author":"Murgatroyd","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib53","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/oxfordjournals.schbul.a033408","article-title":"Schizophrenia: an epigenetic puzzle?","volume":"25","author":"Petronis","year":"1999","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib54","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0801853105","article-title":"Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder","volume":"105","author":"Pibiri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib55","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update","volume":"10","author":"Rapaport","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib56","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbagen.2009.06.009","article-title":"Epigenetic mechanisms in schizophrenia","volume":"1790","author":"Roth","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.mp.4001954","article-title":"Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection","volume":"12","author":"Ruzicka","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib58","doi-asserted-by":"crossref","first-page":"16356","DOI":"10.1073\/pnas.0808699105","article-title":"Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons","volume":"105","author":"Satta","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1523\/JNEUROSCI.23-01-00297.2003","article-title":"Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring","volume":"23","author":"Shi","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archpsyc.1996.01830010027005","article-title":"Schizophrenia after prenatal famine. Further evidence","volume":"169","author":"Susser","year":"1996","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopsych.2008.09.002","article-title":"Experience-dependent epigenetic modifications in the central nervous system","volume":"65","author":"Sweatt","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib62","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11689-011-9079-2","article-title":"DNA methylation, the early-life social environment and behavioral disorders","volume":"3","author":"Szyf","year":"2011","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cne.10905","article-title":"Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse","volume":"467","author":"Tamamaki","year":"2003","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib64","article-title":"Prenatal stress, gestational age and secondary sex ratio: the sex-specific effects of exposure to a natural disaster in early pregnancy","author":"Torche","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib65","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neures.2010.12.010","article-title":"A\u00a0heterozygous deletion in the glutamate decarboxylase 67 gene enhances maternal and fetal stress vulnerability","volume":"69","author":"Uchida","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib67","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/nar\/gkh739","article-title":"Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2)","volume":"32","author":"Valinluck","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib68","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1073\/pnas.0409665102","article-title":"In psychosis, cortical interneurons overexpress DNA-methyltransferase 1","volume":"102","author":"Veldic","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.schres.2006.11.029","article-title":"Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder","volume":"91","author":"Veldic","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.57.3.237","article-title":"Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia","volume":"57","author":"Volk","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib71","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1523\/JNEUROSCI.4164-06.2007","article-title":"The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes","volume":"27","author":"Weaver","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib72","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4161\/epi.2.1.3881","article-title":"Epigenetic programming by maternal behavior and pharmacological intervention. Nature versus nurture: let's call the whole thing off","volume":"2","author":"Weaver","year":"2007","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2012.04.013_bib73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs and schizophrenia: a search for common ground","volume":"16","author":"Weinberg","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib74","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S1461145708009206","article-title":"Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia","volume":"12","author":"Winter","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.brainres.2008.03.092","article-title":"Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia","volume":"1218","author":"Woo","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib76","doi-asserted-by":"crossref","first-page":"13130","DOI":"10.1523\/JNEUROSCI.1039-10.2010","article-title":"Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus","volume":"30","author":"Zhang","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2009.03.020","article-title":"An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes","volume":"111","author":"Zhubi","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.04.013_bib78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychires.2004.08.008","article-title":"Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring","volume":"39","author":"Zuckerman","year":"2005","journal-title":"J.\u00a0Psychiatr. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T23:00:02Z","timestamp":1561676402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":78,"alternative-id":["S0028390812001499"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.04.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}